Leadership & Pay ·
On June 19, 2026, the Board of Directors of Grifols, S.A. acknowledged the resignation of Enriqueta Felip Font from…
GRFSGrifols SA
On June 19, 2026, the Board of Directors of Grifols, S.A. acknowledged the resignation of Enriqueta Felip Font from the Board and the Sustainability, Communication and Reputation Committee for professional reasons. The Board appointed Ester Masllorens Llinàs as an independent director via co-option to fill the vacancy. Additionally, Pascal Ravery was appointed to the Sustainability, Communication and Reputation Committee to replace Ms. Felip Font. Grifols, S.A. is a pharmaceutical company specializing in plasma-derived medicines.